JOHN KIRKWOOD to Risk
This is a "connection" page, showing publications JOHN KIRKWOOD has written about Risk.
Connection Strength
0.100
-
Adjuvant therapy with high-dose interferon alpha 2b in patients with high-risk stage IIB/III melanoma. Nat Clin Pract Oncol. 2008 Jan; 5(1):2-3.
Score: 0.063
-
Correlation of molecular human leukocyte antigen typing and outcome in high-risk melanoma patients receiving adjuvant interferon. Cancer. 2010 Sep 15; 116(18):4326-33.
Score: 0.019
-
Independence of dysplastic nevi from total nevi in determining risk for nonfamilial melanoma. Prev Med. 1988 May; 17(3):273-9.
Score: 0.016
-
Intralymphatic and regional surgical adjuvant immunotherapy in high-risk melanoma of the extremities. Surgery. 1982 Sep; 92(3):459-63.
Score: 0.003